Results
152
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
152 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
JFLLIFE | ₹21.05 | -5.6% | 32.9% | ₹694.6m | n/a | PE13x | n/a | 0.4% | ||
540937 | ₹65.38 | -1.7% | -25.0% | ₹5.4b | n/a | PE61.3x | n/a | n/a | ||
531726 | ₹165.25 | -10.7% | -20.4% | ₹1.9b | n/a | PE14.3x | n/a | 1.9% | ||
SUNPHARMA | ₹1,643.75 | -3.3% | 5.3% | ₹3.9t | ₹2,076.97 | PE34.5x | E12.5% | 0.9% | ||
INFINIUM | ₹244.50 | 1.3% | 2.5% | ₹3.4b | n/a | PE35.8x | n/a | n/a | ||
538964 | ₹857.70 | 1.0% | -6.7% | ₹1.0b | n/a | PE26.1x | n/a | 0.4% | ||
ALKEM | ₹4,601.25 | -1.1% | -15.1% | ₹550.1b | ₹5,395.95 | PE25.6x | E9.9% | 0.9% | ||
ACCENTMIC | ₹229.35 | -5.0% | -16.0% | ₹4.8b | n/a | PE14.8x | n/a | 0.4% | ||
532384 | ₹146.75 | 2.8% | -20.4% | ₹1.5b | n/a | PE11.1x | n/a | 1.7% | ||
524774 | ₹1,098.95 | -0.2% | -48.6% | ₹6.8b | n/a | PE20.8x | n/a | 0.2% | ||
500488 | ₹28,944.20 | 3.9% | 0.9% | ₹615.0b | ₹29,838.57 | PE46.1x | E11.2% | 1.4% | ||
524075 | ₹892.25 | 4.5% | -34.1% | ₹5.1b | n/a | PE12.6x | n/a | 1.3% | ||
SUVENPHAR | ₹1,226.45 | 12.6% | 84.5% | ₹312.2b | ₹1,467.50 | PE111.8x | E45.1% | 0% | ||
524661 | ₹7.28 | -21.4% | 54.9% | ₹98.4m | n/a | PE5.2x | n/a | n/a | ||
524828 | ₹293.00 | 1.8% | -8.0% | ₹1.7b | n/a | PE17.3x | n/a | 1.5% | ||
BETA | ₹1,649.30 | -7.3% | 29.2% | ₹15.9b | n/a | PE38.7x | n/a | n/a | ||
INNOVACAP | ₹784.15 | -5.0% | 47.5% | ₹44.9b | ₹1,066.00 | PE35.2x | E33.4% | n/a | ||
RPGLIFE | ₹2,370.05 | 5.7% | 45.8% | ₹39.2b | n/a | PE49.5x | n/a | 0.7% | ||
524396 | ₹50.75 | -2.2% | -27.3% | ₹825.9m | n/a | PE136.1x | n/a | n/a | ||
LYKALABS | ₹118.41 | -2.2% | -4.8% | ₹4.2b | n/a | PE100.7x | n/a | n/a | ||
CIPLA | ₹1,475.75 | 1.1% | 0.6% | ₹1.2t | ₹1,644.19 | PE23.9x | E3.6% | 0.9% | ||
524394 | ₹947.45 | -15.4% | 93.1% | ₹21.0b | n/a | PE38.6x | n/a | 0.2% | ||
500672 | ₹836.00 | 4.2% | -17.9% | ₹20.6b | n/a | PE23.9x | n/a | 3.0% | ||
DIVISLAB | ₹5,757.05 | -1.5% | 57.8% | ₹1.5t | ₹5,845.75 | PE73.9x | E22.0% | 0.5% |